• facebook
  • linkedin
  • youtube

Kusvika Chikumi 25, 2021, National Health Commission yeChina yakaburitsa data rinoratidza kuti vanhu vanopfuura 630 miriyoni vakabaiwa munyika yangu, izvo zvinoreva kuti huwandu hwejekiseni hwehuwandu hwese muChina hwakapfuura makumi mana muzana, inova nhanho yakakosha mukutanga kudzivirira kwemombe.

Saka vanhu vazhinji vanozonetsekana kuti vanoziva sei kana vakagadzira masoja ekudzivirira chirwere mushure mekugamuchira mushonga mutsva wekudzivirira?

Parizvino, iyo inonyanya kuzivikanwa korona antibody yekuona kit pamusika ndeye IgM/IgG antibody yekuona kit (colloidal goridhe nzira).

Coronavirus (COV) imhuri hombe yemavhairasi anokonzera zvirwere kubva kuchikosoro kusvika kuzvirwere zvakakomba senge acute acute breathing syndrome (SARS-CoV).SARS-CoV-2 idambudziko idzva risati rawanikwa muvanhu.Chirwere cheCoronavirus 2019 ″ (COVID-19) chinokonzerwa nehutachiona "SARS-COV-2" hutachiona.Varwere veSARS-CoV-2 vakataura zviratidzo zvinyoro (kusanganisira vamwe varwere vasina kutaura zviratidzo) kusvika zvakanyanya.COVID -19 Zviratidzo zvinotaridza sefivha, kupera simba, chikosoro chakaoma, kushomeka kwekufema uye zvimwe zviratidzo, izvo zvinogona kukurumidza kuita mabayo, kutadza kufema, kuvhunduka kweseptic, kutadza kwenhengo dzakawanda, yakanyanya acid-base metabolism disorder, nezvimwe.

Iyo itsva coronavirus IgM/IgG antibody yekuona kit yakagadzirirwa kuona zvine hunyanzvi masoja ekudzivirira chirwere eSARS-CoV-2 uye woishandisa sechishandiso chekubatsira kuongororwa kwehutachiona hweSARS-CoV-2.

Kuonekwa musimboti

Iyo kit ine (1) musanganiswa we recombinant neocoronavirus antigen mamaki uye emhando yekudzora mapuroteni mamaki uye (2) mitsara miviri yekuona (T1 neT2, yakateedzana yakavharwa neanopesana nevanhu IgM neIgG antibodies) uye tambo yekudzora mhando (inosanganisira Neye-anti-quality control protein antibody).Kana sample yawedzerwa kune bvunzo tambo, iyo goridhe-yakanyorwa recombinant SARS-CoV-2 protein inosunga kune hutachiona IgM uye/kana IgG masoja ekudzivirira chirwere aripo mumuenzaniso kuti agadzire antigen-antibody complex.Aya macomplexes anofamba achitevedza bvunzo tambo, obva atorwa neanopesana nevanhu IgM pamutsetse weT1, uye/kana neanorwisa-munhu IgG antibody pamutsetse weT2, bhendi repepuru-tsvuku rinoonekwa munzvimbo yekuyedza, zvichiratidza mhedzisiro yakanaka.Kana pasina anti-SRAS-CoV-2 antibody mumuenzaniso kana mwero weanorwisa utachiona mumuenzaniso wakadzikira, hapazove nemitsetse yepepuru-tsvuku pa“T1 neT2″.Iyo "quality control line" inoshandiswa pakugadzirisa maitiro.Kana iyo nzira yekuyedza iri kuenderera mberi uye ma reagents ari kushanda nemazvo, tambo yekudzora mhando inofanirwa kugara ichionekwa.

Inopihwa reagents

Imwe neimwe kit ine:

Item

Zvikamu

Tsanangudzo/Kuwanda

1

Kadhi rekuyedza rimwe nerimwe rakaiswa mualuminium foil bag, ine desiccant

news_icoBQ-02011

news_icoBQ-02012

1

20

2

Sample buffer (Tris buffer, detergent, preservative)

1ml

5ml

3

Mirayiridzo yekushandisa

1

1

Detection process

Verenga bhuku rino zvakanyatsonaka usati washanda kuti udzivise mhedzisiro isiriyo.

1. Usati waedzwa, mareagents ose anofanira kuenzana nekushisa kwekamuri (18 kusvika 25 ° C).

2. Bvisa kadhi rekuedza kubva muhombodo yealuminium foil uye uiise panzvimbo yakaoma, yakaoma.

3. Nhanho yekutanga: Shandisa pipette kana kutumira pipette kuwedzera 10μL ye serum / plasma, kana 20μL yemunwe ropa rose kana venous ropa rose kune sampuli zvakanaka.

4. Danho 2: Pakarepo wedzera madonhwe maviri (60µL) emuenzaniso buffer kune muenzaniso mutsime.

5. Nhanho 3: Apo muedzo unotanga kushanda, unogona kuona ruvara rutsvuku ruchifamba pahwindo rekuita pakati pekadhi rekuedza, uye chigumisiro chekuedza chichawanikwa mukati memaminitsi 10-15..

news_pic_1

Dudziro yezvabuda

Zvakanaka (+)

 nhau_pic_2

1. Pane mitsara mitsvuku mitatu (T1, T2, uye C) muhwindo rekuita.Hazvina mhosva kuti ndeupi mutsara unotanga, inoratidza kuvepo kweiyo itsva coronavirus IgM uye IgG masoja ekudzivirira chirwere.

2. Kune mitsara mitsvuku miviri (T1 neC) muhwindo rekuita, zvisinei kuti ndeupi mutsara unotanga kuoneka, inoratidza kuvapo kwehutachiona hwehutachiona hweIgM.

3. Kune mitsetse miviri yakatsvuka (T2 neC) muhwindo rekuita, zvisinei kuti ndeupi mutsara unotanga, inoratidza kuvapo kweiyo coronavirus itsva IgG antibodies.

Negative(-)

 news_pic_3

1. Chete "C" mutsara (mhando yekudzora mutsara) muhwindo rekuita inoratidza kuti hapana masoja ekudzivirira chirwere chekoronavirus akaonekwa, uye mhedzisiro yacho yakaipa.

Hazvina basa

 news_pic_4

1. Kana mutsara wehutano (C) usina kuratidzwa mukati memaminitsi e10-15, mugumisiro wekuedza hauna kukodzera pasinei nokuti pane T1 uye / kana T2 mutsara.Inokurudzirwa kuongorora zvakare.

2. Mhedzisiro yebvunzo haishande mushure memaminitsi gumi nemashanu.

 

Saka iwe unogona kuita iyi bvunzo kumba, email kana kufona kuti uwane rumwe ruzivo nezve Sars-CoV-2 IgM/IgG antibody yekuona kit (colloidal goridhe nzira).


Nguva yekutumira: Jul-01-2021